Tag: Artificial General Intelligence

Browse our exclusive articles!

ChatGPT and other large language models to disrupt daily life, warns computing science expert

Discover how ChatGPT and other large language models are expected to disrupt daily lives, according to computing science expert Joemon M. Jose. Explore the limitations and potential applications of these models.

Sam Altman’s Reasons for Leading OpenAI: More Than Just Money

Explore the insights of Sam Altman, the CEO of OpenAI, who reveals why not having an equity stake in the AI startup doesn't bother him and how Microsoft's investment of $13bn is fueling the AI industry.

ChatGPT Introduces New Features and Reduced API Prices

OpenAI's language models, GPT-3 and GPT-4, now offer new features with improved performance, including a function calling feature and more reliable steerability. API access prices have also been lowered, making the technology more accessible for developers and individuals. OpenAI aims to democratize the benefits of artificial general intelligence and continues to work on updates for ChatGPT with new plugins now in public testing.

AI Risks and Benefits Will Rise Together, Warns ChatGPT CEO

OpenAI plans to establish an office in Japan due to their high regard for human and machine collaboration. CEO Sam Altman discusses the need for global regulation of AI to balance benefits with potential risks.

Age of AI: Everything You Need to Know About Artificial Intelligence

Discover the latest advancements in Artificial Intelligence (AI) that are permeating modern life, from entertainment to business and even dating. Learn about neural networks, generative AI, and the key players in the industry. Stay informed as this rapidly-changing landscape transforms our world. #AI #technology #neuralnetworks #innovation

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img